Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000842023-12-000021

VP Hematology Operations sold 475 shares at $67.57 ($32,096)

  • VP Hematology Operations acquired 475 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

VERONNEAU MARCEL · VP Hematology Operations

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2012-08-14 Exercise or conversion : show line 1 in the form +475 $51.60 $24,510 35,044 D
2012-08-14 Sale : show line 2 in the form −475 $67.57 $32,096 34,569 D
Open-market sales · 475 sh · avg $67.57 · $32,096

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-08-14 Exercise or conversion : show line 3 in the form Stock Option −475 $51.60 2012-08-17 475 0 D
Loading xslF345X03/primary_doc.xml…